What should I Know Regarding Pregnancy, Nursing and Administering Pitavastatin Tablet to Children or the Elderly?
If you are PREGNANT
- Known or Theoretical Risk:
If you are NURSING
- Absolute Contraindication: OTHER SIMILAR DRUGS EXCRETED INTO BREAST MILK; CAUTION ADVISED
If you are an adult over 60
- Management or Monitoring Precaution: Renal- Adjust starting dose and do not exceed a maximum of 2 mg/day for CrCL<60 mL/min. Hepatic-Monitor hepatic transaminases. Musculoskeletal-Elderly patients greater than age 65 may be at increased risk for myopathy and rhabdomyolysis. Rhabdomyolysis and myopathy risk is greatest when starting or increasing dose. Gastrointestinal-Constipation risk. In clinical trials, approximately 2% of patients experienced constipation.
Giving Pitavastatin Tablet to a child under 12
- Management or Monitoring Precaution: Safety and efficacy not established in age < 8 years; limited data support use in age > 6 years.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.